Solid State Characterization of the Consciousness Energy Healing Treated Ferrous Sulphate

Ferrous sulphate is an inorganic iron salt used for the prevention and treatment of iron deficiency anaemia. The study aimed to evaluate the effects of the Trivedi Effect®- Consciousness Energy Healing Treatment on the solid state properties of ferrous sulphate using sophisticated analytical techniques. The test compound, ferrous sulphate was divided into two parts and named as the control and treated sample. The control ferrous sulphate did not receive Biofield Energy Treatment; however, the Treated sample received the Trivedi Effect®-Consciousness Energy Healing Treatment remotely by the well-known Biofield Energy Healer, Dahryn Trivedi (USA) for 3 minutes. The PXRD relative peak intensities and crystallite size of the treated sample were significantly changed from -66.93% to 331.88% and -24.92% to 139.87%, respectively compared with the control sample. The particle size in the treated sample values were significantly decreased by 17.56% (d10), 26.94% (d50), 31.66% (d90), and 28.98% {D(4,3)}, respectively; however, the specific surface area was significantly increased by 29.57% compared to the control sample. The melting point of the treated ferrous sulphate in the 1st and 3rd peaks was decreased by 4.06% and 2.55% respectively, while increased by 8.40% and 0.17% in the 2nd and 4th peaks, respectively compared to the control sample. The total latent heat of fusion was significantly decreased by 23.22% in the treated sample compared with the control sample. The total weight loss in the treated ferrous sulphate was increased by 2.00% compared with the control sample. The maximum thermal decomposition temperature of the treated ferrous sulphate was decreased by 2.14%, 16.53%, 3.89%, and 2.21% in the 1st, 2nd, 3rd, and 4th peak respectively, compared to the control sample. The Biofield Energy Treatment might lead to the production of a new polymorphic form of iron sulphate. The Biofield Energy Treated ferrous sulphate would be useful to design more efficacious nutraceutical/pharmaceutical formulations, which might offer better therapeutic response against iron deficiency anaemia.

The Trivedi Effect® - Consciousness Energy Healing Treatment has the astounding capability to modify the solid state charateristics of ferrous sulphate. The XRD relative peak intensities of the treated sample were significantly changed from -66.93% to 331.88% compared to the control sample. Subsequently, the crystallites size of the Biofield Energy Treated ferrous sulphate were significantly altered from -24.92% to 139.87% compared with the control sample. The particle size in the Biofield Energy Treated ferrous sulphate at d10, d50, d90, and D (4,3) values were significantly reduced by 17.56%, 26.94%, 31.66%, and 28.98%, respectively compared with the control sample. The specific surface area of the Biofield Energy Treated sample was significantly increased by 29.57% compared with the control ferrous sulphate. The melting temperature of the treated sample in the 1st and 3rd peaks was lowered by 4.06% and 2.55% respectively, while enhanced by 8.40% and 0.17% in the 2nd and 4th peaks, respectively compared with the control sample. The latent heat of fusion was significantly reduced by 23.22% in the Biofield Energy Treated sample compared with the control sample. The total weight loss in the Biofield Energy Treated sample was increased by 2.00% compared with the control sample. The Tmax of the treated ferrous sulphate was decreased by 2.14%, 16.53%, 3.89%, and 2.21% in the 1st, 2nd, 3rd, and 4th peak respectively, compared to the control sample. The Trivedi Effect®-Consciousness Energy Healing Treatment might lead to the production of a polymorphic form of ferrous sulphate having decreased particle size and improved surface area, which might increase the dissolution rate and bioavailability of ferrous sulphate compared with the control sample. The Biofield Energy Treated ferrous sulphate would be suitable to design more efficacious nutraceutical/pharmaceutical formulations, which might offer better therapeutic response against iron deficiency anaemia.